Donna J.C. Fanelli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Donna Fanelli, DNP is a nurse practitioner dually certified in Acute Care and Adult health and holds a Doctorate of Nursing Practice.
A performance-focused leader with a proven background across the healthcare spectrum simultaneously
developing and implementing initiatives for high utilization of healthcare services and patient satisfaction.
Founder and Director of a primary care health center and co-founder of a clinical research site for the study of liver and digestive diseases, Dr. Fanelli has more than 20 years’ experience in all aspects of critical-care nursing. Currently the clinical director of a corporate health center at a global law firm headquartered in New York, NY. Fanelli's experience extends across the healthcare spectrum to all areas of critical care and primary care. She notably contributed to several publications, including her dissertation on pre-treatment education for Chronic Hepatitis C therapy. Her academic dedication earned her a place on the Dean's List during her undergraduate studies at The College of Staten Island and Dr. Fanelli has precepted many nurse practitioner students towards excellence in nursing practice.
Education & Training
- Wilkes UniversityDoctorate, 2011 - 2013
- Seton Hall UniversityMasters, 2000
- College of Staten IslandBSN, 1993
Awards, Honors, & Recognition
- Deans List The College of Staten Island
Professional Memberships
- Member
- Member
- American Association of Parkinsons DiseaseVice Chair
- American Association of Critical Care NursesMember
Publications & Presentations
Journal Articles
- Helping Patients Stay the Course on Treatment for Hepatitis CProjects in Knowledge, 1/1/2004
- 3 vs 5 Million units of Interferon in Combination with Ribavirin in Treatment Naive PatientsStein, L., Fanelli, D., et al, Am. J. Gastro, 1/1/2002
Lectures
- Interferon-Induced Sarcoidosis; A Case Study1/1/2013
- Those HCV Mutations1/1/2013
- Emerging Treatment Options and Novel Therapies for the Treatment of Chronic Hepatitis CSouth Plainfield, NJ - 1/1/2010
- Join now to see all
Other
- A Discussion on HCV, What you Need to KnowThe American Liver Foundation Webinar
1/1/2014 - Mount Sinai Expert Guides: Hepatology
1/1/2014 - Dissertation, Dissertation: Utilizing Pre-Treatment Education to Optimize Adherence to Triple Therapy for the Treatment of Chronic Hepatitis CWilkes University
1/1/2013
Office
1221 Avenue of the Americas
50th Floor
New York, NY 10020Phone+1 212-819-8955Fax+1 212-218-0185
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: